Skip to main content
eScholarship
Open Access Publications from the University of California

Vitiligo-like lesions located over In-transit metastases of malignant melanoma as a clinical marker of complete response to pembrolizumab.

  • Author(s): Gracia-Cazaña, Tamara
  • Padgett, Esteban
  • Hernández-García, Alba
  • Sánchez-Salas, María Pilar
  • et al.
Creative Commons 'BY-NC-ND' version 4.0 license
Abstract

Anti-programmed cell death (PD)-1 therapies in metastatic tumors have a high incidence of immune adverse events, including cutaneous manifestations such as vitiligo-like lesions. This side effect is associated with increased survival and it is a clinical marker of response to treatment. This case report is a graphic representation of the appearance of vitiligo-like lesions over in-transit metastases of malignant melanoma linked to a complete response to treatment with pembrolizumab.

Main Content
Current View